
World ADC, Frankfurt
February 17 - 20, 2014
Bad Homburg, Germany
Doors open at:
About the Event
World ADC Frankfurt 2014 has been uniquely designed through a series of industry brainstorming sessions. This year’s agenda has been crafted to deliver genuine insight on selecting the best possible candidate and getting it to the clinic faster. Select your lead candidate with confidence. Improve preclinical predictability. Maximise clinical efficacy
Our Speakers

AB
Alain Beck
Head of Physico-Chemistry
Pierre Fabre

AL
Alexey Lugovskoy
Merrimack
Merrimack

AM
Andreas Maderna
Associate Research Fellow, Medicinal Chemistry
Pfizer

AG
Anna Grabowska
Associate Professor, Division of Preclinical Oncology,
University of Nottingham

CC
Carmen Cuevas
Director, R&D
Pharmamar

CL
Chris Lloyd
Senior Scientist, Antibody Discovery & Protein Engineering,
MedImmune

CS
Christof Seidle
Department of Nuclear Medicine,
Technische Universität München

CW
Cynthia Wooge
Global Strategic Marketing
SAFC

DL
Dale Ludwig
Director
Eli Lilly

DB
David Bramhill
Founder
Bramhill Biological Consulting

DR
David Rabuka
CSO
Redwood Bioscience

DS
David Satijn
Genmab
Genmab

DS
David Stover
Director
Agensys/Astellas

DV
Dr.Stephane Varray
Business Development, Custom Development
Lonza

ER
Ed Reilly
Associate Director, Cancer Therapeutic Abs
Abbvie

FV
Floris van Delft
CSO
Synaffix

FP
Franck Pavan
Manager, Outsourcing & Business Development
Pierre Fabre

GP
Gail Phillips
Senior Scientist, Research Oncology, Genentech,
Genentech

GB
George Badescu
Head of Bioconjugation and Bioanalysis
PolyTherics

GN
Gerhard Niederfellner
Head, Tumour Biology, pRED
Roche

GP
Gillian Payne
Senior Director, BioAnalytical Science
ImmunoGen

GC
Giulio Casi
Head, Antibody Drug Conjugates,
Philochem

GB
Goncalo Bernardes
Department of Chemistry
Cambridge University

HW
Herren Wu
Director
MedImmune

JR
Joe Reddy
Director of Pharmacology
Endocyte

JL
John Lambert
CSO
ImmunoGen

JS
Jonas Schaefer
Head of High-Throughput Laboratory
University of Zurich

KY
Kee Yin Cheung
RA Project Manager
Lonza

LM
Laura Melendez-Alafort
Department of Surgery, Oncology & Gastroenterology
University of Padua

MM
Malin Mejàre
CSO
Genovis

MM
Matthias Machacek
Group Lead, Medical Engineering
Novartis

ML
Melissa Lapierre-Devlin
Senior Scientist
Takeda Boston

ML
Mr. Lee Allen
Principal Group Leader
Lonza

MG
Ms. Gayle Allway
Senior Bio-technologist
Lonza

NH
Nahor Haddish-Berhane
Senior Principal Scientist
Pfizer

NB
Nia Beckley
Senior Research Associate
Genentech

PV
Patrick Vincent
Head, TCAL Oncology Research
Takeda San Diego

PG
Patrizio Giacomini
Immunology Lab
Istituto Nazionale Tumori

PH
Pernille Høyrup Hemmingsen
CMC Project Manager
Genmab

PB
Peter Bach
Director
BioPharmaLogic

PS
Peter Senter
VP, Chemistry
Seattle Genetics

PS
Peter Senter,
VP, Chemistry,
Seattle Genetics

RC
Ravi Chari
Executive Director - Chemistry & Biochemistry
ImmunoGen

RK
Rebecca Kristeleit
Senior Lecturer & Honorary Consultant, Early Phase Clinical Studies
UCL

SP
Sarah Pogue
Director, Target Validation
Teva

SG
Shalom Goldberg
Research Scientist
Johnson & Johnson

SB
Stefan Bracht
Director Formulation Development Liquids
Bayer

SC
Stephane Cornen
Head of Biochemistry & Characterisation
Sanofi

TM
Thi-Sau Migone
CSO
Igenica

TH
Thomas Haeder
Manager Corporate Clinical Research
Biotest

UG
Ulf Grawunder
CEO
NBE-Therapeutics

UB
Ulrich Brinkmann
Scientific Director
Roche

